Johan Vad‐Nielsen

MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells

Kristine Raaby Jakobsen, Christina Demuth, Anne Tranberg Madsen et al. · Oncogenesis · 2017 · 80 citations · Full text

Cell Proliferation, Nsclc Hcc827 Cells, Hcc827er Cells +19

Golden Gate Assembly of CRISPR gRNA expression array for simultaneously targeting multiple genes

Johan Vad‐Nielsen, Lin Lin, Lars Bolund et al. · Cellular and Molecular Life Sciences · 2016 · 76 citations · Full text

Systems Biology, Engineering, Off-target Effect +11

Histone Deacetylase Inhibitor Romidepsin Inhibits<i>De Novo</i>HIV-1 Infections

Kasper L. Jønsson, Martin Tolstrup, Johan Vad‐Nielsen et al. · Antimicrobial Agents and Chemotherapy · 2015 · 28 citations · Full text

Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC

Kristine Raaby Gammelgaard, Johan Vad‐Nielsen, Michelle Simone Clement et al. · Translational Oncology · 2018 · 24 citations · Full text

Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells

Johan Vad‐Nielsen, Kristine Raaby Gammelgaard, Tina Fuglsang Daugaard et al. · Lung Cancer · 2019 · 24 citations

Epithelial-mesenchymal Transition, Pathology, Epithelial-mesenchymal Interactions +8